LONDON, Aug 18 (Reuters) - An H1N1 swine flu vaccine developed by China's Sinovac Biotech is effective after just one shot, its developer said on Tuesday. Sign up here. The news boosted shares in the ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on ...
It is time to act. Your vote at the upcoming Special Meeting of Shareholders will shape SINOVAC’s future. SAIF has called this Special Meeting to reconstitute a remnant of the Former Board that the UK ...
Sinovac Biotech ((SVA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results